The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS

Human Molecular Genetics

Volumn 20, Issue 20, 2011, Pages 3986-3996

  Maxwell, Michele M ^a,b   Tomkinson, Elizabeth M ^a   Nobles, Johnathan ^a   Wizeman, John W ^a   Amore, Allison M ^a   Quinti, Luisa ^a,b   Chopra, Vanita ^a,b   Hersch, Steven M ^a,b   Kazantsev, Aleksey G ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; ALPHA TUBULIN; HYDROLASE; SIRTUIN 2; SIRTUIN 2 MICROTUBULE DEACETYLASE; TUBULIN ACETYLTRANSFERASE; UNCLASSIFIED DRUG;

ACETYLATION; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BRAIN CORTEX; CELL DIFFERENTIATION; CELL DIVISION; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME ACTIVITY; FEMALE; MALE; MICROTUBULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM;

AGING; ANIMALS; CELL LINE, TUMOR; CENTRAL NERVOUS SYSTEM; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE ORDER; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICROTUBULES; NEURONS; PROTEIN ISOFORMS; SIRTUIN 2;

MAMMALIA; MUS;

EID: 80053137033     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr326     Document Type: Article

References (47)

1. Blander, G. and Guarente, L. (2004) The Sir2 family of protein deacetylases. Annu. Rev. Biochem., 73, 417-435.
2. Denu, J.M. (2005) The Sir 2 family of protein deacetylases. Curr. Opin. Chem. Biol., 9, 431-440.
3. Donmez, G. and Guarente, L. (2010) Aging and disease: connections to sirtuins. Aging Cell, 9, 285-290.
4. Kaeberlein, M., McVey, M. and Guarente, L. (1999) The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev., 13, 2570-2580.
5. Rogina, B. and Helfand, S.L. (2004) Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc. Natl Acad. Sci. USA, 101, 15998-16003.
6. Michan, S. and Sinclair, D. (2007) Sirtuins in mammals: insights into their biological function. Biochem. J., 404, 1-13.
7. Taylor, D.M., Maxwell, M.M., Luthi-Carter, R. and Kazantsev, A.G. (2008) Biological and potential therapeutic roles of sirtuin deacetylases. Cell. Mol. Life Sci., 65, 4000-4018.
8. Harting, K. and Knoll, B. (2010) SIRT2-mediated protein deacetylation: an emerging key regulator in brain physiology and pathology. Eur. J. Cell. Biol., 89, 262-269.
9. Pfister, J.A., Ma, C., Morrison, B.E. and D'Mello, S.R. (2008) Opposing effects of sirtuins on neuronal survival: SIRT1-mediated neuroprotection is independent of its deacetylase activity. PLoS One, 3, e4090.
10. Suzuki, K. and Koike, T. (2007) Mammalian Sir2-related protein (SIRT) 2-mediated modulation of resistance to axonal degeneration in slow Wallerian degeneration mice: a crucial role of tubulin deacetylation. Neuroscience, 147, 599-612.
11. Outeiro, T.F., Kontopoulos, E., Altmann, S.M., Kufareva, I., Strathearn, K.E., Amore, A.M., Volk, C.B., Maxwell, M.M., Rochet, J.C., McLean, P.J. et al. (2007) Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease. Science, 317, 516-519.
12. Luthi-Carter, R., Taylor, D.M., Pallos, J., Lambert, E., Amore, A., Parker, A., Moffitt, H., Smith, D.L., Runne, H., Gokce, O. et al. (2010) SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis. Proc. Natl Acad. Sci. USA, 107, 7927-7932.
13. +-dependent tubulin deacetylase. Mol. Cell, 11, 437-444.
14. Dryden, S.C., Nahhas, F.A., Nowak, J.E., Goustin, A.S. and Tainsky, M.A. (2003) Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle. Mol. Cell. Biol., 23, 3173-3185.
15. Werner, H.B., Kuhlmann, K., Shen, S., Uecker, M., Schardt, A., Dimova, K., Orfaniotou, F., Dhaunchak, A., Brinkmann, B.G., Mobius, W. et al. (2007) Proteolipid protein is required for transport of sirtuin 2 into CNS myelin. J. Neurosci., 27, 7717-7730.
16. Li, W., Zhang, B., Tang, J., Cao, Q., Wu, Y., Wu, C., Guo, J., Ling, E.A. and Liang, F. (2007) Sirtuin 2, a mammalian homolog of yeast silent information regulator-2 longevity regulator, is an oligodendroglial protein that decelerates cell differentiation through deacetylating alphα-tubulin. J. Neurosci., 27, 2606-2616.
17. Creppe, C., Malinouskaya, L., Volvert, M.L., Gillard, M., Close, P., Malaise, O., Laguesse, S., Cornez, I., Rahmouni, S., Ormenese, S. et al. (2009) Elongator controls the migration and differentiation of cortical neurons through acetylation of alphα-tubulin. Cell, 136, 551-564.
18. Solinger, J.A., Paolinelli, R., Kloss, H., Scorza, F.B., Marchesi, S., Sauder, U., Mitsushima, D., Capuani, F., Sturzenbaum, S.R. and Cassata, G. (2010) The Caenorhabditis elegans Elongator complex regulates neuronal alphα-tubulin acetylation. PLoS Genet., 6, e1000820.
19. Janke, C. and Kneussel, M. (2010) Tubulin post-translational modifications: encoding functions on the neuronal microtubule cytoskeleton. Trends Neurosci., 33, 362-372.
20. Perdiz, D., Mackeh, R., Pous, C. and Baillet, A. (2011) The ins and outs of tubulin acetylation: more than just a post-translational modification? Cell Signal., 23, 763-771.
21. De Vos, K.J., Grierson, A.J., Ackerley, S. and Miller, C.C. (2008) Role of axonal transport in neurodegenerative diseases. Annu. Rev. Neurosci., 31, 151-173.
22. Nguyen, L., Humbert, S., Saudou, F. and Chariot, A. (2010) Elongator -an emerging role in neurological disorders. Trends Mol. Med., 16, 1-6.
23. Creppe, C. and Buschbeck, M. (2011) Elongator: an ancestral complex driving transcription and migration through protein acetylation. J. Biomed. Biotechnol., 2011, 924898.
24. Dompierre, J.P., Godin, J.D., Charrin, B.C., Cordelieres, F.P., King, S.J., Humbert, S. and Saudou, F. (2007) Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation. J. Neurosci., 27, 3571-3583.
25. Tapia, M., Wandosell, F. and Garrido, J.J. (2010) Impaired function of HDAC6 slows down axonal growth and interferes with axon initial segment development. PLoS One, 5, e12908.
26. Chen, S., Owens, G.C., Makarenkova, H. and Edelman, D.B. (2010) HDAC6 regulates mitochondrial transport in hippocampal neurons. PLoS One, 5, e10848.
27. Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X.F. and Yao, T.P. (2002) HDAC6 is a microtubule-associated deacetylase. Nature, 417, 455-458.
28. Matsuyama, A., Shimazu, T., Sumida, Y., Saito, A., Yoshimatsu, Y., Seigneurin-Berny, D., Osada, H., Komatsu, Y., Nishino, N., Khochbin, S. et al. (2002) In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation. EMBO J., 21, 6820-6831.
29. Zhang, Y., Li, N., Caron, C., Matthias, G., Hess, D., Khochbin, S. and Matthias, P. (2003) HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo. EMBO J., 22, 1168-1179.
30. Pandithage, R., Lilischkis, R., Harting, K., Wolf, A., Jedamzik, B., Luscher-Firzlaff, J., Vervoorts, J., Lasonder, E., Kremmer, E., Knoll, B. et al. (2008) The regulation of SIRT2 function by cyclin-dependent kinases affects cell motility. J. Cell Biol., 180, 915-929.
31. Nahhas, F., Dryden, S.C., Abrams, J. and Tainsky, M.A. (2007) Mutations in SIRT2 deacetylase which regulate enzymatic activity but not its interaction with HDAC6 and tubulin. Mol. Cell. Biochem., 303, 221-230.
32. Zhang, Y., Kwon, S., Yamaguchi, T., Cubizolles, F., Rousseaux, S., Kneissel, M., Cao, C., Li, N., Cheng, H.L., Chua, K. et al. (2008) Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally. Mol. Cell. Biol., 28, 1688-1701.
33. Southwood, C.M., Peppi, M., Dryden, S., Tainsky, M.A. and Gow, A. (2007) Microtubule deacetylases, SirT2 and HDAC6, in the nervous system. Neurochem. Res., 32, 187-195.
34. Quinti, L., Chopra, V., Rotili, D., Valente, S., Amore, A., Franci, G., Meade, S., Valenza, M., Altucci, L., Maxwell, M.M. et al. (2010) Evaluation of histone deacetylases as drug targets in Huntington's disease models. Study of HDACs in brain tissues from R6/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell model. PLoS Curr., 2, RRN1172.
35. Vaquero, A., Scher, M.B., Lee, D.H., Sutton, A., Cheng, H.L., Alt, F.W., Serrano, L., Sternglanz, R. and Reinberg, D. (2006) SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis. Genes Dev., 20, 1256-1261.
36. Jing, E., Gesta, S. and Kahn, C.R. (2007) SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation. Cell Metab., 6, 105-114.
37. Wang, F. and Tong, Q. (2009) SIRT2 suppresses adipocyte differentiation by deacetylating FOXO1 and enhancing FOXO1's repressive interaction with PPARgamma. Mol. Biol. Cell, 20, 801-808.
38. Wang, F., Nguyen, M., Qin, F.X. and Tong, Q. (2007) SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction. Aging Cell, 6, 505-514.
39. Reed, N.A., Cai, D., Blasius, T.L., Jih, G.T., Meyhofer, E., Gaertig, J. and Verhey, K.J. (2006) Microtubule acetylation promotes kinesin-1 binding and transport. Curr. Biol., 16, 2166-2172.
40. Hammond, J.W., Huang, C.F., Kaech, S., Jacobson, C., Banker, G. and Verhey, K.J. (2010) Posttranslational modifications of tubulin and the polarized transport of kinesin-1 in neurons. Mol. Biol. Cell, 21, 572-583.
41. Mattson, M.P. and Magnus, T. (2006) Ageing and neuronal vulnerability. Nat. Rev. Neurosci., 7, 278-294.
42. Gauthier, L.R., Charrin, B.C., Borrell-Pages, M., Dompierre, J.P., Rangone, H., Cordelieres, F.P., De Mey, J., MacDonald, M.E., Lessmann, V., Humbert, S. et al. (2004) Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell, 118, 127-138.
43. Simpson, C.L., Lemmens, R., Miskiewicz, K., Broom, W.J., Hansen, V.K., van Vught, P.W., Landers, J.E., Sapp, P., Van Den Bosch, L., Knight, J. et al. (2009) Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration. Hum. Mol. Genet., 18, 472-481.
44. Slaugenhaupt, S.A., Blumenfeld, A., Gill, S.P., Leyne, M., Mull, J., Cuajungco, M.P., Liebert, C.B., Chadwick, B., Idelson, M., Reznik, L. et al. (2001) Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. Am. J. Hum. Genet., 68, 598-605.
45. Gardiner, J., Barton, D., Marc, J. and Overall, R. (2007) Potential role of tubulin acetylation and microtubule-based protein trafficking in familial dysautonomia. Traffic, 8, 1145-1149.
46. Maxwell, M.M., Pasinelli, P., Kazantsev, A.G. and Brown, R.H. Jr. (2004) RNA interference-mediated silencing of mutant superoxide dismutase rescues cyclosporin A-induced death in cultured neuroblastoma cells. Proc. Natl Acad. Sci. USA, 101, 3178-3183.
47. Valencia, A., Reeves, P.B., Sapp, E., Li, X., Alexander, J., Kegel, K.B., Chase, K., Aronin, N. and DiFiglia, M. (2010) Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease. J. Neurosci. Res., 88, 179-190.